Autologous stem cell transplantation in Hodgkin's disease

被引：3

作者：

Avivi, I ^{[1
]}

Goldstone, AH ^{[1
]}

机构：

[1] UCL Hosp, London, England

来源：

ANNALS OF ONCOLOGY | 2002年 / 13卷

关键词：

D O I：

10.1093/annonc/13.S1.122

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：122 / 127

页数：6

共 42 条

[21] Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
Lazarus, HM
Loberiza, FR
Zhang, MJ
Armitage, JO
Ballen, KK
Bashey, A
Bolwell, BJ
Burns, LJ
Freytes, CO
Galeg, RP
Gibson, J
Herzig, RH
LeMaistre, CF
Marks, D
Mason, J
Miller, AM
Milone, GA
Pavlovsky, S
Reece, DE
Rizzo, JD
van Besien, K
Vose, JM
Horowitz, MM
[J]. BONE MARROW TRANSPLANTATION, 2001, 27 (04) : 387 - 396
[22] DOSE INTENSIFICATION WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED AND RESISTANT HODGKINS-DISEASE - RESULTS OF A BNLI RANDOMIZED TRIAL
LINCH, DC
WINFIELD, D
GOLDSTONE, AH
MOIR, D
HANCOCK, B
MCMILLAN, A
CHOPRA, R
MILLIGAN, D
HUDSON, GV
[J]. LANCET, 1993, 341 (8852) : 1051 - 1054
[23] CONVENTIONAL-DOSE SALVAGE COMBINATION CHEMOTHERAPY IN PATIENTS RELAPSING WITH HODGKINS-DISEASE AFTER COMBINATION CHEMOTHERAPY - THE LOW PROBABILITY FOR CURE
LONGO, DL
DUFFEY, PL
YOUNG, RC
HUBBARD, SM
IHDE, DC
GLATSTEIN, E
PHARES, JC
JAFFE, ES
URBA, WJ
DEVITA, VT
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) : 210 - 218
[24] Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease
Martín, A
Fernández-Jiménez, MC
Caballero, MD
Canales, MA
Pérez-Simón, JA
de Bustos, JG
Vázquez, L
Hernández-Navarro, F
San Miguel, JF
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (01) : 161 - 171
[25] Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease
Milpied, N
Fielding, AK
Pearce, RM
Ernst, P
Goldstone, AH
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1291 - 1296
[26] A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model
Moskowitz, CH
Nimer, SD
Zelenetz, AD
Trippett, T
Hedrick, EE
Filippa, D
Louie, D
Gonzales, M
Walits, J
Coady-Lyons, N
Qin, J
Frank, R
Bertino, JR
Coy, A
Noy, A
O'Brien, JP
Straus, D
Portlock, CS
Yahalom, J
[J]. BLOOD, 2001, 97 (03) : 616 - 623
[27] HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS BONE-MARROW AND/OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE - RESULTS IN 85 PATIENTS WITH ANALYSIS OF PROGNOSTIC FACTORS
NADEMANEE, A
ODONNELL, MR
SNYDER, DS
SCHMIDT, GM
PARKER, PM
STEIN, AS
SMITH, EP
MOLINA, A
STEPAN, DE
SOMLO, G
MARGOLIN, KA
SNIECINSKI, I
DAGIS, AC
NILAND, J
PEZNER, R
FORMAN, SJ
[J]. BLOOD, 1995, 85 (05) : 1381 - 1390
[28] Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantation
Nagler, A
Ackerstein, A
Or, R
Naparstek, E
Slavin, S
[J]. BLOOD, 1997, 89 (11) : 3951 - 3959
[29] Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies
Park, S
Brice, P
Noguerra, ME
Simon, D
Rousselot, P
Kerneis, Y
Morel, P
Marolleau, JP
Gisselbrecht, C
[J]. BONE MARROW TRANSPLANTATION, 2000, 26 (03) : 321 - 326
[30] PHILLIPS GL, 1989, BLOOD, V73, P2086

← 1 2 3 4 5 →